JP2025501452A5 - - Google Patents

Info

Publication number
JP2025501452A5
JP2025501452A5 JP2024533052A JP2024533052A JP2025501452A5 JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5 JP 2024533052 A JP2024533052 A JP 2024533052A JP 2024533052 A JP2024533052 A JP 2024533052A JP 2025501452 A5 JP2025501452 A5 JP 2025501452A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence described
binding substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024533052A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025501452A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081253 external-priority patent/WO2023108114A2/en
Publication of JP2025501452A publication Critical patent/JP2025501452A/ja
Publication of JP2025501452A5 publication Critical patent/JP2025501452A5/ja
Pending legal-status Critical Current

Links

JP2024533052A 2021-12-10 2022-12-09 ヒトメソテリン結合物質 Pending JP2025501452A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163288162P 2021-12-10 2021-12-10
US63/288,162 2021-12-10
PCT/US2022/081253 WO2023108114A2 (en) 2021-12-10 2022-12-09 Human mesothelin binders

Publications (2)

Publication Number Publication Date
JP2025501452A JP2025501452A (ja) 2025-01-22
JP2025501452A5 true JP2025501452A5 (cg-RX-API-DMAC7.html) 2025-12-15

Family

ID=86731328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024533052A Pending JP2025501452A (ja) 2021-12-10 2022-12-09 ヒトメソテリン結合物質

Country Status (8)

Country Link
EP (1) EP4444757A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025501452A (cg-RX-API-DMAC7.html)
KR (1) KR20240114766A (cg-RX-API-DMAC7.html)
CN (1) CN118660911A (cg-RX-API-DMAC7.html)
AU (1) AU2022407541A1 (cg-RX-API-DMAC7.html)
CA (1) CA3239553A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024007054A (cg-RX-API-DMAC7.html)
WO (1) WO2023108114A2 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20150074T1 (hr) * 2007-10-01 2015-03-13 Bristol-Myers Squibb Company Humana antitijela koja se vežu za mezotelin i njihove uporabe
AU2011349443B2 (en) * 2010-12-20 2015-12-24 Genentech, Inc. Anti-mesothelin antibodies and immunoconjugates
WO2014004549A2 (en) * 2012-06-27 2014-01-03 Amgen Inc. Anti-mesothelin binding proteins
US10730954B2 (en) * 2017-05-12 2020-08-04 Harpoon Therapeutics, Inc. MSLN targeting trispecific proteins and methods of use
GB201811450D0 (en) * 2018-07-12 2018-08-29 F Star Delta Ltd Mesothelin and CD137 binding molecules
CN114008071B (zh) * 2018-12-27 2025-01-21 吉加根公司 抗ctla-4结合蛋白及其使用方法
CN114585416B (zh) * 2019-04-01 2025-01-17 莱克制药股份有限公司 用于调节免疫应答和治疗疾病的btla结合(cd272)抗体

Similar Documents

Publication Publication Date Title
CN110799539B (zh) 抗4-1bb抗体及其制备和使用方法
JP2023503180A (ja) 抗ヒトクローディン18.2抗体及びその適用
JP2023511774A5 (cg-RX-API-DMAC7.html)
JP2021516973A5 (cg-RX-API-DMAC7.html)
US20200347130A1 (en) CD96 Antibody, Antigen-Binding Fragment and Pharmaceutical use Thereof
JP2021533726A5 (cg-RX-API-DMAC7.html)
JP2021525546A5 (cg-RX-API-DMAC7.html)
RU2012112340A (ru) Гуманизированные моноклональные антитела к сеа с созревшей аффинностью
JP2006506955A5 (cg-RX-API-DMAC7.html)
JP2010504755A5 (cg-RX-API-DMAC7.html)
KR920702425A (ko) Cdr 이식된 항-cea 항체 및 그의 제조
JP2013524773A5 (cg-RX-API-DMAC7.html)
JP2021524478A5 (cg-RX-API-DMAC7.html)
JP2023549537A5 (cg-RX-API-DMAC7.html)
JP2022532173A5 (cg-RX-API-DMAC7.html)
RU2008126242A (ru) Антитела против глобуломера а бета, их антигенсвязывающие части, соответствующие гибридомы, нуклеиновые кислоты, векторы, клетки-хозяева, способы получения указанных антител, композиции, содержащие указанные антитела, применения указанных антител и способы использования указанных антител
RU2011103125A (ru) КОМБИНАЦИЯ АНТАГОНИСТА c-Met И АМИНОГЕТЕРОАРИЛА ДЛЯ ЛЕЧЕНИЯ РАКА
JP2023548529A5 (cg-RX-API-DMAC7.html)
JP2019205480A5 (cg-RX-API-DMAC7.html)
JP2024541680A5 (cg-RX-API-DMAC7.html)
JP2024016024A5 (cg-RX-API-DMAC7.html)
JP2023517794A5 (cg-RX-API-DMAC7.html)
JP2022517216A5 (cg-RX-API-DMAC7.html)
CN114591434A (zh) 抗Siglec15抗体及其制备方法和用途
CN112480259A (zh) 抗tnfr2抗体及其用途